These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2978891)
21. Antiidiotypic activity and sensitization after donor-specific transfusion (DST) given with and without cyclosporin A (CsA). Hillis AN; MacLeod AM; al-Muzairai IA; Innes A; Stewart KN; Power DA; Bone MJ; Sells RA; Catto GR Transplant Proc; 1989 Feb; 21(1 Pt 2):1820-1. PubMed ID: 2652591 [No Abstract] [Full Text] [Related]
22. Donor specific blood transfusions do not improve graft survival in living related donor transplantation. Garcia VD; Kraemer ES; Prompt CA; Santos A; Caovila J; Duarte A; Filho AN; Goldani JC Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507 [No Abstract] [Full Text] [Related]
23. Mismatched living, related donor renal transplantation: a prospective, randomized study. Sommer BG; Ferguson RM Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539 [TBL] [Abstract][Full Text] [Related]
24. Kidney transplantation in rhesus monkeys. Matching for D/DR antigens, pretransplant blood transfusions, and immunological monitoring before transplantation. Borleffs JC; Marquet RL; de By-Aghai Z; van Vreeswijk W; Neuhaus P; Balner H Transplantation; 1982 Mar; 33(3):285-90. PubMed ID: 6461114 [TBL] [Abstract][Full Text] [Related]
26. [Immunological analysis of mixed lymphocyte culture reaction inhibitory factor induced by donor specific blood transfusions in potential kidney transplant patients]. Takeuchi H Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):339-49. PubMed ID: 3157045 [TBL] [Abstract][Full Text] [Related]
27. Transplant outcome of desensitized recipients after donor-specific transfusion. Okazaki H; Takahashi H; Oguma S; Jimbo M; Ishizaki M Transplant Proc; 1987 Feb; 19(1 Pt 1):750-2. PubMed ID: 3274863 [No Abstract] [Full Text] [Related]
28. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions. Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589 [TBL] [Abstract][Full Text] [Related]
29. FoxP3 positive T cells in graft biopsies from living donor kidney transplants after donor-specific transfusions. Eisenberger U; Seifried A; Patey N; Kappeler A; Noel LH; Frey FJ; Körner M Transplantation; 2009 Jan; 87(1):138-42. PubMed ID: 19136904 [TBL] [Abstract][Full Text] [Related]
30. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
31. Effect of donor-specific transfusions on renal transplantation in children. Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150 [TBL] [Abstract][Full Text] [Related]
32. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants. Lazda VA; Jonasson O; Mozes MF Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829 [No Abstract] [Full Text] [Related]
33. Three year experience of donor specific transfusion and concomitant cyclosporine A. Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890 [No Abstract] [Full Text] [Related]
34. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971 [TBL] [Abstract][Full Text] [Related]
35. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients. Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683 [TBL] [Abstract][Full Text] [Related]
36. Anti-idiotypic autoantibodies after donor-specific blood transfusions. Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864 [No Abstract] [Full Text] [Related]
37. Effect of DST combined with cyclosporine on lymphocyte subsets of potential recipients for living-related donor renal allograft. Murai M; Nakamura H; Sekiguchi S; Shimizu S; Nakajima F Transplant Proc; 1994 Aug; 26(4):1950-1. PubMed ID: 8066631 [No Abstract] [Full Text] [Related]
38. Kidney transplantation from living unrelated donors. Alfani D; Pretagostini R; Bruzzone P; Smits J; Persijn G; Cortesini R Clin Transpl; 1998; ():205-12. PubMed ID: 10503099 [TBL] [Abstract][Full Text] [Related]
39. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs. Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545 [No Abstract] [Full Text] [Related]